The United Nations Conference on Trade and Development has reportedly encouraged Bangladesh to open its markets, particularly its pharmaceutical industry, to foreign investment should the nation wish to continue its economic development.
According to reports, UNCTAD concluded its sixth session of its Investment, Enterprise and Development Commission on Friday to promote entrepreneurship and technological innovation.
The session included the presentation of UNCTAD’s investment policy review of Bangladesh, concluding that the nation has “an enormous potential” to attract foreign direct investment considering its strategic position between two emerging markets, among other benefits.
UNCTAD reportedly recommended investment policy reforms and, in particular, to relax is pharmaceutical regulation that has largely weakened foreign investment in the industry.
Bangladesh reportedly said it would carefully review the recommendations.
Full content: Intellectual Property Watch
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI